Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

In many patients with deep vein thrombosis and pulmonary embolism (venous thromboembolism, VTE), biomarkers or genetic risk factors have not been identified. To discover novel plasma metabolites associated with VTE risk, we employed liquid chromatography-mass spectrometry-based untargeted metabolomi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Deguchi, Hiroshi, Banerjee, Yajnavalka, Trauger, Sunia, Siuzdak, Gary, Kalisiak, Ewa, Fernández, José A., Hoang, Linh, Tran, Minerva, Yegneswaran, Subramanian, Elias, Darlene J., Griffin, John H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2015
Gaiak:
Thrombosis and Hemostasis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582336/
https://ncbi.nlm.nih.gov/pubmed/26175037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-636761
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak